FolioLanternBeta
MIRMMirum Pharmaceuticals, Inc.

Jolanda Howe

SVP, Global Controller at Mirum Pharmaceuticals, Inc., as of Sep 3, 2026Sold $5.6M of stock in the past 12 months: 15% under a disclosed plan, 13% to cover taxes and 72% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
99%†
share of stake sold at Mirum Pharmaceuticals, Inc.
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
616
shares held after the latest filing, Mirum Pharmaceuticals, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $167K to cover taxesJanFeb 2026: $100K to cover taxesFebMar 2026: $435K to cover taxesMarAprMayJun 2026: $264K under a disclosed planJunJul 2026: $327K under a disclosed planJulAug 2026: $194K under a disclosed planAug 2026: $4.0M no plan disclosed$4.2MAugSep 2026: $66K under a disclosed planSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Mirum Pharmaceuticals, Inc. (MIRM)SVP, Global ControllerMay 9, 2023Sep 3, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.